| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 392,828 | 369,058 | 415,697 | 398,893 | | Cost of Revenue | 44,061 | 45,216 | 46,556 | 42,288 | | | Gross Profit | 348,767 | 323,842 | 369,141 | 356,605 | | | Operating Expenses | | Research Development | 75,160 | 71,037 | 70,114 | 72,500 | | Selling General and Administrative | 226,682 | 222,078 | 228,917 | 230,938 | | Non Recurring | 2,036 | 20,730 | 1,140 |
-
| | Others | 5,163 | 4,994 | 5,849 | 5,468 | | | | Total Operating Expenses | 309,041 | 318,839 | 306,020 |
-
| | | | Operating Income or Loss | 39,726 | 5,003 | 63,121 | 47,699 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,103 | 1,293 | 9,139 | 3,324 | | Earnings Before Interest And Taxes | 44,829 | 6,296 | 72,260 | 51,023 | | Interest Expense | 34 | 124 | 191 | 143 | | Income Before Tax | 44,795 | 6,172 | 72,069 | 50,880 | | Income Tax Expense | 2,276 | (755) | 11,969 | 1,731 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,519 | 6,927 | 60,100 | 49,149 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,519 | 6,927 | 60,100 | 49,149 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,519 | $6,927 | $60,100 | $49,149 |
|
2.03% Nasdaq 
Income Statement
